methotrexate has been researched along with Carcinoma, Adenosquamous in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bahtiyar, M; Chambers, JT; Chambers, SK; Kohorn, EI; McCaffrey, R; Schwartz, PE | 1 |
Cowan, RA; Obasaju, CK; Wilkinson, PM | 1 |
Akamine, T; Hanada, N; Hiraoka, T; Hongo, H; Kitamura, N; Kondo, K; Mori, T; Tabira, Y; Toyota, N; Yoshioka, M | 1 |
Cowie, V; Davidson, SE; Davis, J; Habeshaw, T; Hunter, R; Paul, J; Pyper, E; Reed, NS; Sarkar, T; Stewart, A; Symonds, RP; Yosef, H | 1 |
2 trial(s) available for methotrexate and Carcinoma, Adenosquamous
Article | Year |
---|---|
Neoadjuvant and adjuvant chemotherapy of cervical cancer: mature results of the phase 2 PBM-PFU protocol.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Female; Fluorouracil; Humans; Leucovorin; Maximum Tolerated Dose; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Survival Rate; Treatment Outcome; Uterine Cervical Neoplasms; Young Adult | 2011 |
The Scottish and Manchester randomised trial of neo-adjuvant chemotherapy for advanced cervical cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; England; Female; Humans; Methotrexate; Middle Aged; Neoplasm Staging; Scotland; Treatment Outcome; Uterine Cervical Neoplasms | 2000 |
2 other study(ies) available for methotrexate and Carcinoma, Adenosquamous
Article | Year |
---|---|
Recurrent cervical cancer treated with cisplatin and methotrexate.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Female; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Survival Rate; Uterine Cervical Neoplasms | 1993 |
[Successful chemotherapy based on in vitro chemosensitivity testing in a case of recurrent thymic carcinoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Adenosquamous; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Drug Screening Assays, Antitumor; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Neoplasm Recurrence, Local; Thymus Neoplasms; Tumor Cells, Cultured | 1998 |